Brief: IDL Diagnostics Secures Patent Approval In Hong Kong
Sept 29 (Reuters) - IDL Diagnostics AB (publ) IDLDX.ST: SECURES PATENT APPROVAL IN HONG KONG FOR USE OF TK1 PROTEIN IN RESPIRATORY INFECTIONS Source text: ID:nMFN6bnznM Further company coverage: IDLDX.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))